Entity Details

Primary name CHST8_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9H2A9
EntryNameCHST8_HUMAN
FullNameCarbohydrate sulfotransferase 8
TaxID9606
Evidenceevidence at protein level
Length424
SequenceStatuscomplete
DateCreated2005-03-15
DateModified2021-06-02

Ontological Relatives

GenesCHST8

GO terms

Show/Hide Table
GOName
GO:0000139 Golgi membrane
GO:0001537 N-acetylgalactosamine 4-O-sulfotransferase activity
GO:0006790 sulfur compound metabolic process
GO:0007417 central nervous system development
GO:0008146 sulfotransferase activity
GO:0016021 integral component of membrane
GO:0016051 carbohydrate biosynthetic process
GO:0030166 proteoglycan biosynthetic process
GO:0042446 hormone biosynthetic process

Subcellular Location

Show/Hide Table
Subcellular Location
Golgi apparatus membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR005331 SulfotransferaseFamilyFamily
IPR018011 Carbohydrate sulfotransferase 8-10FamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
616265 OMIMPeeling skin syndrome 3 (PSS3)A form of peeling skin syndrome, a genodermatosis characterized by generalized, continuous shedding of the outer layers of the epidermis. Two main PSS subtypes have been suggested. Patients with non-inflammatory PSS (type A) manifest white scaling, with painless and easy removal of the skin, irritation when in contact with water, dust and sand, and no history of erythema, pruritis or atopy. Inflammatory PSS (type B) is associated with generalized erythema, pruritus and atopy. It is an ichthyosiform erythroderma characterized by lifelong patchy peeling of the entire skin with onset at birth or shortly after. Several patients have been reported with high IgE levels. PSS3 is characterized by generalized white scaling occurring over the upper and lower extremities. Symptoms start during the second half of the first decade of life. The disease is caused by variants affecting the gene represented in this entry.

Interactions

3 interactions